nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CYP2E1—Fingolimod—multiple sclerosis	0.194	0.223	CbGbCtD
Brompheniramine—CYP2D6—Fingolimod—multiple sclerosis	0.0924	0.106	CbGbCtD
Brompheniramine—CYP2E1—Mitoxantrone—multiple sclerosis	0.0912	0.105	CbGbCtD
Brompheniramine—CYP3A4—Fingolimod—multiple sclerosis	0.0588	0.0675	CbGbCtD
Brompheniramine—CYP2C19—Prednisone—multiple sclerosis	0.0475	0.0545	CbGbCtD
Brompheniramine—CYP2E1—Dexamethasone—multiple sclerosis	0.0473	0.0543	CbGbCtD
Brompheniramine—CYP2B6—Dexamethasone—multiple sclerosis	0.0466	0.0536	CbGbCtD
Brompheniramine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0379	0.0435	CbGbCtD
Brompheniramine—CYP2C8—Dexamethasone—multiple sclerosis	0.0353	0.0406	CbGbCtD
Brompheniramine—CYP2C19—Dexamethasone—multiple sclerosis	0.0296	0.034	CbGbCtD
Brompheniramine—CYP3A4—Triamcinolone—multiple sclerosis	0.0287	0.033	CbGbCtD
Brompheniramine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0276	0.0317	CbGbCtD
Brompheniramine—CYP2C9—Dexamethasone—multiple sclerosis	0.0246	0.0283	CbGbCtD
Brompheniramine—CYP3A4—Betamethasone—multiple sclerosis	0.0246	0.0283	CbGbCtD
Brompheniramine—CYP3A4—Prednisolone—multiple sclerosis	0.0243	0.0279	CbGbCtD
Brompheniramine—CYP3A4—Prednisone—multiple sclerosis	0.0229	0.0264	CbGbCtD
Brompheniramine—CYP2D6—Dexamethasone—multiple sclerosis	0.0225	0.0259	CbGbCtD
Brompheniramine—CYP3A4—Dexamethasone—multiple sclerosis	0.0143	0.0165	CbGbCtD
Brompheniramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.56e-05	0.000275	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—POMC—multiple sclerosis	3.53e-05	0.000272	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—CCL2—multiple sclerosis	3.45e-05	0.000266	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CXCL10—multiple sclerosis	3.44e-05	0.000265	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CCL5—multiple sclerosis	3.39e-05	0.000261	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—POMC—multiple sclerosis	3.38e-05	0.000261	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	3.38e-05	0.000261	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.37e-05	0.00026	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	3.37e-05	0.00026	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CCR5—multiple sclerosis	3.36e-05	0.000259	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	3.35e-05	0.000258	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—RRM1—multiple sclerosis	3.34e-05	0.000258	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	3.34e-05	0.000258	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	3.33e-05	0.000257	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—IL2RA—multiple sclerosis	3.31e-05	0.000256	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	3.31e-05	0.000255	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—CCL2—multiple sclerosis	3.3e-05	0.000255	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	3.3e-05	0.000255	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCL10—multiple sclerosis	3.29e-05	0.000254	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	3.29e-05	0.000254	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	3.26e-05	0.000251	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—BCHE—multiple sclerosis	3.24e-05	0.00025	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.19e-05	0.000246	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—TYK2—multiple sclerosis	3.13e-05	0.000242	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCL3—multiple sclerosis	3.09e-05	0.000239	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	3.08e-05	0.000238	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	3.07e-05	0.000237	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	3.05e-05	0.000235	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	3.04e-05	0.000235	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	3.04e-05	0.000235	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	3.03e-05	0.000234	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	3.01e-05	0.000232	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CD86—multiple sclerosis	3e-05	0.000232	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	3e-05	0.000232	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—TYK2—multiple sclerosis	3e-05	0.000231	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	3e-05	0.000231	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	2.99e-05	0.000231	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	2.98e-05	0.00023	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	2.97e-05	0.000229	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	2.96e-05	0.000228	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	2.96e-05	0.000228	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCL5—multiple sclerosis	2.96e-05	0.000228	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PGR—multiple sclerosis	2.93e-05	0.000226	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	2.93e-05	0.000226	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PGR—multiple sclerosis	2.92e-05	0.000226	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PGR—multiple sclerosis	2.91e-05	0.000225	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.91e-05	0.000224	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.91e-05	0.000224	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PGR—multiple sclerosis	2.89e-05	0.000223	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CD86—multiple sclerosis	2.88e-05	0.000222	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	2.88e-05	0.000222	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—IL2—multiple sclerosis	2.87e-05	0.000221	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	2.87e-05	0.000221	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	2.86e-05	0.00022	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CD28—multiple sclerosis	2.85e-05	0.00022	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.84e-05	0.000219	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CD28—multiple sclerosis	2.84e-05	0.000219	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCL5—multiple sclerosis	2.83e-05	0.000219	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CD28—multiple sclerosis	2.83e-05	0.000218	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	2.83e-05	0.000218	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CD28—multiple sclerosis	2.8e-05	0.000216	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCR2—multiple sclerosis	2.8e-05	0.000216	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	2.79e-05	0.000215	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.79e-05	0.000215	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	2.78e-05	0.000214	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	2.75e-05	0.000212	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—IL2—multiple sclerosis	2.75e-05	0.000212	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—SPP1—multiple sclerosis	2.74e-05	0.000211	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.74e-05	0.000211	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—BCHE—multiple sclerosis	2.73e-05	0.000211	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCR5—multiple sclerosis	2.66e-05	0.000206	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.66e-05	0.000205	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL2RA—multiple sclerosis	2.63e-05	0.000203	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	2.63e-05	0.000203	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SPP1—multiple sclerosis	2.62e-05	0.000202	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	2.62e-05	0.000202	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	2.61e-05	0.000201	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL2—multiple sclerosis	2.61e-05	0.000201	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.59e-05	0.0002	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	2.58e-05	0.000199	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CNR1—multiple sclerosis	2.58e-05	0.000199	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	2.57e-05	0.000199	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	2.57e-05	0.000198	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCR5—multiple sclerosis	2.55e-05	0.000197	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	2.54e-05	0.000196	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL2RA—multiple sclerosis	2.52e-05	0.000194	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.5e-05	0.000193	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL2—multiple sclerosis	2.5e-05	0.000193	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.44e-05	0.000189	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—APOE—multiple sclerosis	2.42e-05	0.000187	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—POMC—multiple sclerosis	2.38e-05	0.000184	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	2.38e-05	0.000183	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	2.37e-05	0.000183	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—BCHE—multiple sclerosis	2.36e-05	0.000182	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	2.35e-05	0.000181	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	2.33e-05	0.00018	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	2.33e-05	0.000179	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	2.32e-05	0.000179	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—APOE—multiple sclerosis	2.32e-05	0.000179	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	2.32e-05	0.000179	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	2.32e-05	0.000179	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	2.31e-05	0.000178	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	2.3e-05	0.000177	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	2.29e-05	0.000176	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.23e-05	0.000172	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.23e-05	0.000172	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.2e-05	0.00017	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CD80—multiple sclerosis	2.19e-05	0.000169	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	2.12e-05	0.000163	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	2.11e-05	0.000163	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—BCHE—multiple sclerosis	2.11e-05	0.000162	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	2.11e-05	0.000162	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CD80—multiple sclerosis	2.1e-05	0.000162	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	2.08e-05	0.000161	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—POMC—multiple sclerosis	2.08e-05	0.000161	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCL2—multiple sclerosis	2.04e-05	0.000157	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CD86—multiple sclerosis	2.03e-05	0.000157	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.03e-05	0.000157	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CD86—multiple sclerosis	2.03e-05	0.000156	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CD86—multiple sclerosis	2.02e-05	0.000156	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCL5—multiple sclerosis	2e-05	0.000154	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CD86—multiple sclerosis	2e-05	0.000154	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—POMC—multiple sclerosis	1.99e-05	0.000154	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	1.99e-05	0.000154	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—MAPK1—multiple sclerosis	1.99e-05	0.000154	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	1.99e-05	0.000153	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	1.97e-05	0.000152	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCL2—multiple sclerosis	1.95e-05	0.000151	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—APOE—multiple sclerosis	1.95e-05	0.00015	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	1.94e-05	0.00015	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.94e-05	0.000149	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	1.94e-05	0.000149	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	1.93e-05	0.000149	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.92e-05	0.000148	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	1.91e-05	0.000147	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—MAPK1—multiple sclerosis	1.91e-05	0.000147	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	1.85e-05	0.000143	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TYK2—multiple sclerosis	1.85e-05	0.000143	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	1.85e-05	0.000143	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	1.84e-05	0.000142	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	1.82e-05	0.000141	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	1.8e-05	0.000139	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	1.8e-05	0.000139	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	1.79e-05	0.000138	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	1.78e-05	0.000137	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	1.77e-05	0.000137	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TYK2—multiple sclerosis	1.77e-05	0.000137	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	1.77e-05	0.000137	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	1.77e-05	0.000136	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	1.76e-05	0.000136	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	1.76e-05	0.000136	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	1.75e-05	0.000135	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	1.75e-05	0.000135	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	1.73e-05	0.000134	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—APOE—multiple sclerosis	1.68e-05	0.000129	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—POMC—multiple sclerosis	1.67e-05	0.000129	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—APOE—multiple sclerosis	1.64e-05	0.000127	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—APOE—multiple sclerosis	1.64e-05	0.000127	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—APOE—multiple sclerosis	1.63e-05	0.000126	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—APOE—multiple sclerosis	1.63e-05	0.000126	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	1.61e-05	0.000125	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL2—multiple sclerosis	1.54e-05	0.000119	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	1.53e-05	0.000118	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ALB—multiple sclerosis	1.53e-05	0.000118	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CD80—multiple sclerosis	1.48e-05	0.000114	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CD80—multiple sclerosis	1.48e-05	0.000114	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL2—multiple sclerosis	1.47e-05	0.000114	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CD80—multiple sclerosis	1.47e-05	0.000114	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	1.47e-05	0.000113	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	1.46e-05	0.000113	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	1.46e-05	0.000112	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—POMC—multiple sclerosis	1.44e-05	0.000111	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—APOE—multiple sclerosis	1.42e-05	0.00011	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—POMC—multiple sclerosis	1.41e-05	0.000109	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—POMC—multiple sclerosis	1.41e-05	0.000109	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—POMC—multiple sclerosis	1.4e-05	0.000108	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—POMC—multiple sclerosis	1.4e-05	0.000108	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	1.4e-05	0.000108	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	1.39e-05	0.000107	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	1.38e-05	0.000106	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	1.37e-05	0.000106	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	1.37e-05	0.000106	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	1.36e-05	0.000105	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	1.35e-05	0.000104	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.34e-05	0.000104	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	1.34e-05	0.000103	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	1.33e-05	0.000102	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ALB—multiple sclerosis	1.31e-05	0.000101	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	1.3e-05	0.0001	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ALB—multiple sclerosis	1.29e-05	9.92e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—APOE—multiple sclerosis	1.27e-05	9.78e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.27e-05	9.77e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	1.25e-05	9.66e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	1.25e-05	9.63e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	1.24e-05	9.6e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	1.24e-05	9.57e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	1.23e-05	9.5e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—POMC—multiple sclerosis	1.22e-05	9.41e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MYC—multiple sclerosis	1.2e-05	9.29e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	1.2e-05	9.27e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	1.18e-05	9.09e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—APOE—multiple sclerosis	1.17e-05	8.99e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—APOE—multiple sclerosis	1.16e-05	8.91e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MYC—multiple sclerosis	1.15e-05	8.9e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	1.15e-05	8.87e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	1.13e-05	8.7e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ALB—multiple sclerosis	1.11e-05	8.58e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—POMC—multiple sclerosis	1.09e-05	8.4e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2—multiple sclerosis	1.04e-05	8.04e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2—multiple sclerosis	1.04e-05	8.01e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	1.04e-05	8e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2—multiple sclerosis	1.03e-05	7.99e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	1.03e-05	7.97e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	1.03e-05	7.95e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	1.02e-05	7.91e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	1.02e-05	7.87e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—POMC—multiple sclerosis	1e-05	7.72e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—POMC—multiple sclerosis	9.92e-06	7.66e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ALB—multiple sclerosis	9.92e-06	7.66e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	9.86e-06	7.61e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	9.83e-06	7.58e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	9.79e-06	7.56e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	9.7e-06	7.48e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ALB—multiple sclerosis	9.13e-06	7.04e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—multiple sclerosis	9.05e-06	6.98e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ALB—multiple sclerosis	9.05e-06	6.98e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	8.76e-06	6.76e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	8.74e-06	6.74e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	8.71e-06	6.72e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—multiple sclerosis	8.67e-06	6.69e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	8.62e-06	6.65e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MYC—multiple sclerosis	8.14e-06	6.28e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	8.12e-06	6.27e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MYC—multiple sclerosis	8.12e-06	6.26e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	8.1e-06	6.25e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MYC—multiple sclerosis	8.09e-06	6.24e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	8.07e-06	6.23e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	8.01e-06	6.18e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	7.99e-06	6.17e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	7.97e-06	6.15e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	7.94e-06	6.13e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	7.92e-06	6.11e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	7.84e-06	6.05e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—APOE—multiple sclerosis	7.62e-06	5.88e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—POMC—multiple sclerosis	6.54e-06	5.05e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—multiple sclerosis	6.12e-06	4.72e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—multiple sclerosis	6.1e-06	4.71e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—multiple sclerosis	6.08e-06	4.69e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	6.02e-06	4.65e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALB—multiple sclerosis	5.97e-06	4.6e-05	CbGpPWpGaD
